Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406921 | 1.00 | ALDH1A1 (0.46) | ALDH1A1HRH3LOXL2ABATCYP1A2 | |
| Iodide SCHEMBL31233435 | 0.97 | ALDH1A1 (0.44) | ALDH1A1HRH3LOXL2ABATCYP1A2 | |
| SCHEMBL27925720 | 0.84 | CYP1A2 (0.39) | ALDH1A1LOXL2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9294913 | 0.81 | HRH3 (0.61) | ALDH1A1HRH3LOXL2ABATCYP3A4 | |
| SCHEMBL8141320 | 0.80 | HRH3 (0.40) | HRH3LOXL2ABATESR1ESR2 | |
| SCHEMBL8211010 | 0.80 | ALDH1A1 (0.52) | ALDH1A1HRH3LOXL2ABATCYP1A2 | |
| SCHEMBL2036306 | 0.80 | SKP2 (0.59) | ALDH1A1HRH3LOXL2CYP1A2CYP3A4 | |
| SCHEMBL2221947 | 0.80 | TAAR1 (0.43) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL718078 | 0.80 | TAAR1 (0.56) | ALDH1A1CYP1A2CYP2D6PNMTCYP2A6 | |
| SCHEMBL24219430 | 0.78 | HRH3 (0.39) | HRH3LOXL2ABATESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926893-B | Recyclable cleaning agent and preparation method and application thereof | 中国科学院化学研究所 | 2024-06-25 | — | — | CN | claimed |
| CN-115926893-A | Recyclable cleaning agent and preparation method and application thereof | 中国科学院化学研究所 | 2023-04-07 | — | — | CN | claimed |
| US-11034650-B2 | Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection | INTERVET INC. (US) | 2021-06-15 | — | — | US | claimed |
| CN-112624930-A | Preparation method of 2, 2-bis (4-aminophenyl) hexafluoropropane | 上海如鲲新材料有限公司 | 2021-04-09 | — | — | CN | claimed |
| CN-111777553-A | Preparation method of isoquinoline compounds | 苏州大学 | 2020-10-16 | — | — | CN | claimed |
| EP-1773768-B1 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2018-08-22 | — | — | EP | claimed |
| CN-105505128-B | Near-infrared light response self-repairing coating and preparation method thereof | 南京工业大学 | 2018-05-08 | — | — | CN | claimed |
| CN-105505128-A | Near-infrared light response self-repairing coating and preparation method thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2016-04-20 | — | — | CN | claimed |
| CN-102911124-A | Hydroxy-pyrimidone compound and preparation method and application thereof | UNIV SHANDONG | 2013-02-06 | — | — | CN | claimed |
| EP-1360186-B1 | CARBOLINE DERIVATIVES | LILLY ICOS LLC (US) | 2006-11-22 | — | — | EP | claimed |
| EP-1019367-A1 | DERIVATIVES OF 2,5- AND 3,5-DISUBSTITUTED ANILINES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2000-07-19 | — | — | EP | claimed |
| WO-1999007672-A1 | DERIVATIVES OF 2,5- AND 3,5-DISUBSTITUTED ANILINES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1999-02-18 | — | — | WO | claimed |
| EP-4691607-A1 | DRAW SOLUTE, DRAW SOLUTION, AND WATER TREATMENT METHOD | Nippon Shokubai Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20250346602-A1 | LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF | DICE ALPHA INC (US) | 2025-11-13 | — | — | US | disclosed |
| WO-2025213277-A1 | N1-(3,4-DICHLOROPHENYL)MALEAMIDE DERIVATIVES AND THE USE THEREOF IN THE TREATMENT OF INFLAMMATORY DISORDERS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025137329-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA, INC (US) | 2025-06-26 | — | — | WO | disclosed |
| US-4276297-A | ANTIULCER AGENTS | PFIZER INC. (US) | 1981-06-30 | — | — | US | disclosed |
| US-4009279-A | 2-IMINO-1,3-DITHIETANES | AMERICAN CYANAMID COMPANY (US) | 1977-02-22 | — | — | US | disclosed |
| US-3997668-A | INSECTICIDES, MITICIDE | AMERICAN CYANAMID COMPANY (US) | 1976-12-14 | — | — | US | disclosed |
| US-3975528-A | Insecticidal 2-imino-1,3-dithietane derivatives | AMERICAN CYANAMID COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11034650-B2 | Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection | HEXD, SORD, SDHA | ALDH1A1 951/4885HRH3 43/4885LOXL2 3742/4885 |
| US-20250346602-A1 | LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF | IL17A, IL15, IL18 | ALDH1A1 392/4885HRH3 3734/4885LOXL2 3039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.